Browse 516 coronary artery disease clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Coronary artery disease is the most common type of heart disease, caused by plaque that slowly narrows the arteries feeding the heart and can lead to angina or a heart attack. Much of what doctors do to prevent heart attacks today, from statins to stents to medicines that calm inflammation in the arteries, was proven in large clinical trials. Even so, many people have a heart attack despite good cholesterol numbers, which points to risks current treatment does not fully address.
Location: Quincy MA, Fayetteville NC, Tamarac FL, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07157774
Phase 3, Recruiting
Active & Responsive
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
for
Menopause, Menopause Hot Flashes, Menopause Related Conditions,
Location: Richmond VA, Chapel Hill NC, Aurora CO
Sponsor: University of Colorado, Denver
Sex: Female
Age: 45 - 55
Code: NCT06975111
Phase 2, Phase 3, Recruiting
Active & Responsive
Omega-3D: Omega-3 for Diet-Driven Health Disparities
for
Heart Health Markers, Cardiovascular Diseases,
Location: Tucson AZ
Sponsor: University of Arizona
Sex: All
Age: 18 - 64
Code: NCT07078344
Phase 2, Recruiting
Active & Responsive
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
for
Hypertension, Cardiovascular Diseases
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 35 - 65
Code: NCT04715022
Phase 1, Phase 2, Recruiting
Active & Responsive
Impact of Lean Pork on Endothelial Function in Perimenopause
for
Cardiovascular Outcome, Overweight and Obese Women,
Location: Baton Rouge LA
Sponsor: Pennington Biomedical Research Center
Sex: Female
Age: 40 - 55
Code: NCT06976112
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
for
Venous Thromboses, Venous Disease, Venous Leg Ulcer,
Location: Darien CT, Washington D.C. DC, Dallas TX, Seattle WA
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07538609
Recruiting
Active & Responsive
Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
for
Cardiac Rehabilitation, Cardiovascular Diseases
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: Female
Age: 40 - 70+
Code: NCT06784895
Recruiting
Active & Responsive
Evaluation of CCR2 in Patients Post Myocardial Infarction
for
Heart Diseases
Location: Saint Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 21 - 70+
Code: NCT05107596
Phase 1, Recruiting
Active & Responsive
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
for
Type 1 Diabetes, Diabetic Kidney Disease,
Location: Seattle WA
Sponsor: Kalie Tommerdahl
Sex: All
Age: 12 - 25
Code: NCT05065372
Phase 1, Recruiting
Active & Responsive
Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives